Does CANDESARTAN Cause Hyperkeratosis? 8 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Hyperkeratosis have been filed in association with CANDESARTAN. This represents 0.1% of all adverse event reports for CANDESARTAN.
8
Reports of Hyperkeratosis with CANDESARTAN
0.1%
of all CANDESARTAN reports
0
Deaths
1
Hospitalizations
How Dangerous Is Hyperkeratosis From CANDESARTAN?
Of the 8 reports, 1 (12.5%) required hospitalization, and 1 (12.5%) were considered life-threatening.
Is Hyperkeratosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CANDESARTAN. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does CANDESARTAN Cause?
Off label use (1,911)
Fatigue (1,468)
Dyspnoea (1,456)
Pain (1,455)
Drug ineffective (1,428)
Headache (1,371)
Nausea (1,282)
Dizziness (1,237)
Vomiting (1,202)
Diarrhoea (1,145)
What Other Drugs Cause Hyperkeratosis?
CABOZANTINIB S-MALATE (411)
ADALIMUMAB (332)
SUNITINIB MALATE (170)
ETANERCEPT (168)
SORAFENIB (150)
METHOTREXATE (149)
VEMURAFENIB (145)
REGORAFENIB (136)
RIPRETINIB (124)
RITUXIMAB (121)
Which CANDESARTAN Alternatives Have Lower Hyperkeratosis Risk?
CANDESARTAN vs CANDESARTAN CILEXETIL
CANDESARTAN vs CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE
CANDESARTAN vs CANGRELOR
CANDESARTAN vs CANIS LUPUS FAMILIARIS SKIN
CANDESARTAN vs CANNABIDIOL